The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rybakova M.G.

Pavlov First Saint Petersburg State Medical University

Mylnikova A.A.

Pavlov First Saint Petersburg State Medical University

Vlasova M.T.

Acad. I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia

IgG4-related disease of the breast

Authors:

Rybakova M.G., Mylnikova A.A., Vlasova M.T.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2022;84(4): 51‑55

DOI: 10.17116/patol20228404151

Read: 3520 times

Download PDF (RU)
Contact the author
Table of contents

IGG4-RELATED DISEASE OF THE BREAST
IGG4-RELATED DISEASE OF THE BREAST

To cite this article:

Rybakova MG, Mylnikova AA, Vlasova MT. IgG4-related disease of the breast. Russian Journal of Archive of Pathology. 2022;84(4):51‑55. (In Russ.)
https://doi.org/10.17116/patol20228404151

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

IgG4-related disease is an immune-mediated disorder with tumor-like multiorgan involvement, elevated serum IgG4 level and specific histopathological appearance (lymphoplasmacytic infiltrate rich in IgG4+ plasma cells and storiform fibrosis). The article presents rare clinical and morphological observations of IgG4-related mastopathy in women with suspected tumor process. A strategy for the treatment of IgG4-related disease should be based on the results of pre-surgery histopathological examination, which may help to avoid unreasonable surgical intervention and choose glucocorticoids or rituximab as the first-line treatment.

Keywords:

IgG
IgG4-related disease
breast

Authors:

Rybakova M.G.

Pavlov First Saint Petersburg State Medical University

Mylnikova A.A.

Pavlov First Saint Petersburg State Medical University

Vlasova M.T.

Acad. I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia

Received:

19.04.2022

Accepted:

27.04.2022

Close metadata

References:

  1. Maritati F, Peyronel F. VaglioIgG4-related disease: A clinical perspective. Rheumatology. 2020;59:123-131.  https://doi.org/10.1093/rheumatology/kez667
  2. Zen Y, Nakanuma Y. IgG4-related disease: A cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812-1819. https://doi.org/10.1097/PAS.0b013e3181f7266b
  3. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-1192. https://doi.org/10.1038/modpathol.2012.72
  4. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treat-ment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67:1688-1699. https://doi.org/10.1002/art.39132
  5. Kamisawa T, Zen Y, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460-1471. https://doi.org/10.1016/SO140-6736(14)60720-0
  6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22(1):21-30.  https://doi.org/10.1007/s10165-011-0571-z
  7. Umehara H, Okazaki K, Kawa Sh, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Modern Rheumatology. 2021;31:529-533.  https://doi.org/10.1080/14397595.2020.1859710
  8. Wallace Z, Naden R, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77-87.  https://doi.org/10.1136/annrheumdis-2019-216561
  9. Omar D, Chen Y, Dong L, Cong Y. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: A systematic review and network meta-analysis. Rheumatology (Oxford). 2020;59(4):718-726.  https://doi.org/10.1093/rheumatology/kez380
  10. Wang Y, Zhao Z, Gao D, Wang H, et al. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial. Semin Arthritis Rheum. 2020;50(6):15131520. https://doi.org/10.1016/j.semarthrit.2020.01.010
  11. Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171-1177. https://doi.org/10.1136/annrheumdis-2014-206605
  12. Yokoe T, Hayashida T, Kikuchi M, et al. IgG4‐related mastopathy: A case report and literature review. Clin Case Rep. 2018;6(8):1549-1553. https://doi.org/10.1002/ccr3.1657
  13. El-Nayir M, Subramanian A, Ali Z, Howlett D. IgG4-mediated sclerosing fibroinflammatory disease presenting as inflammatory breast malignancy. BJR Case Rep. 2019;5:20180041. https://doi.org/10.1259/bjrcr.20180041
  14. Tsuda B, Kumaki N, Ishida R, et al. Distinction of IgG4-related mastitis from breast cancer: A case report. Surg Case Rep. 2019;5:123.  https://doi.org/10.1186/s40792-019-0681-y
  15. Bajad Sh, Tanna D, Ekboteg G, et al. Immunoglobulin G4-Related Mastitis: An Unusual Case of Recurrent Breast Abscess. Arch Rheumatol. 2020;35(4):623-626.  https://doi.org/10.46497/ArchRheumatol.2020.7567
  16. Erivwo P, Bharatwal V, Huang M, Godra A, Turashvili G. Classic IgG4-related sclerosing mastitis is not so classic. Breast J. 2020;26(6): 1245-1248. https://doi.org/10.1111/tbj.13846
  17. Vitkovski T, Marder G, Filardi D, et al. IgG4-Related Sclerosing Disease of the Breast in a Male Patient. Int J Surg Pathol. 2017;25(8):711-715.  https://doi.org/10.1177/1066896917714324
  18. Asano Y, Kashiwagi Sh, Kawano Y, et al. IgG4-related mastitis requiring differentiation from breast cancer: A case report. Journal of Surgical Case Report. 2021;11:1-3.  https://doi.org/10.1093/jscr/rjaa240
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.